Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V Pantazou

Showing results (1-10 of 2) with videos related to

Pageof 1
Sort By:
Revue Neurologique|February 27, 2021
Is disease activity prior to fingolimod initiation predictive of response? Fingolimod as a "common" first line treatmentV Pantazou, R Du Pasquier, C Pot, et al.
Revue Neurologique|August 11, 2020
First-ever treatment in multiple sclerosisV Pantazou, C Pot, R Du Pasquier, et al.
Pageof 1

Showing results (1-10 of 2) with videos related to

Sort By:
Pageof 1
Revue Neurologique|February 27, 2021
Is disease activity prior to fingolimod initiation predictive of response? Fingolimod as a "common" first line treatmentV Pantazou, R Du Pasquier, C Pot, et al.
Revue Neurologique|August 11, 2020
First-ever treatment in multiple sclerosisV Pantazou, C Pot, R Du Pasquier, et al.
Pageof 1